Recommendations for treating children with drug-resistant tuberculosis

Area of Science:

• Infectious Diseases
• Pediatric Medicine
• Microbiology

Background:

• Tuberculosis (TB) remains a significant global health threat, being the second leading cause of death from infectious diseases.
• Increasing incidence of multidrug-resistant (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) contributes to high mortality rates.
• Pediatric TB management is complex due to limited pediatric-specific drug data, unregistered medications, and lack of suitable formulations for young children.

Purpose of the Study:

• To outline recommendations for the therapeutic approach to pediatric MDR-TB and XDR-TB.
• To address the challenges in treating drug-resistant TB in children.
• To provide guidance for healthcare professionals managing pediatric TB cases.

Main Methods:

• Systematic literature review of existing pediatric TB treatment data.
• Incorporation of clinical experience from a group of scientific societies.
• Development of expert recommendations for therapeutic strategies.

Main Results:

• Drug-resistant TB in children presents unique management difficulties.
• Many effective anti-TB drugs lack pediatric registration and suitable formulations.
• Second-line anti-TB treatments are associated with significant adverse events, requiring careful monitoring.

Conclusions:

• Children with active drug-resistant TB require referral to specialized centers for expert management.
• The complexity of pediatric drug-resistant TB necessitates a multidisciplinary and experienced approach.
• Further research and development of pediatric-specific TB treatments are crucial.